Curanex Pharmaceuticals Inc
CURXBuild a strategy around CURX
Curanex Pharmaceuticals Inc AI Insights
Informational only. Not investment advice.Snapshot
- Zero revenue pre-clinical biotech burning 9.7M TTM cash with 5.8M remaining - under 8 months runway at current rate[Cash and Equivalents]
- Trading at 0.72x book value (14.3M equity vs 10.2M market cap) - market pricing significant dilution or failure risk[P/B Ratio]
- R&D spend of 677K is just 56% of opex - unusually low for biotech, G&A of 274K suggests lean operations[Research and Development]
Watch Triggers
- Cash and Equivalents: Falls below 3M or new equity filing — Signals imminent dilution event - watch for S-3 or ATM filings
- Research and Development: Increases >50% QoQ — Would indicate pipeline advancement but accelerate cash burn timeline
- Total Revenue TTM: Any revenue recognition — Partnership or licensing deal would transform thesis entirely
Bull Case
Clean balance sheet with 0.004 debt/equity and 14.2M working capital provides flexibility for strategic pivots or partnerships
Sub-book valuation (0.72x) means successful pipeline news could drive 40%+ upside to tangible book alone
Bear Case
Cash runway under 8 months at current burn guarantees near-term dilution; 15.7M recent raise already depleted to 5.8M
ROE of -17.4% and ROA of -17.2% with zero revenue - pure cash burn with no visibility to inflection
Bull vs Bear Balance
AI-generated sentiment analysis based on fundamental metrics and market conditions.
Leverage CURX's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.
Forward Thesis
Equity raise required within 6-9 months to fund operations, likely 30-50% dilution
- Cash burn of 9.7M TTM vs 5.8M cash
- Zero revenue, no near-term path to profitability
- Recent 15.7M capital raise already consumed
Valuation Context
Caveats
Public Strategies Rankings
See how Curanex Pharmaceuticals Inc ranks across different investment strategies.
Leverage CURX's top insights and create a custom strategy in seconds. Our AI editor does it all — in one click.
CURX Fundamentals
| Metric | Value | YoY Growth | Industry Percentile |
|---|---|---|---|
$13.55M | — | ||
$8.93M | — | ||
0.00 | — | ||
$0 | — | ||
$-0.17 | — | ||
0% | — | ||
0% | — | ||
$-10.48M | — | ||
-72.1% | -0.3% | — | |
Beta 5Y (Monthly) | unknown | — |
CURX Dividend History
CURX Stock Splits
CURX SEC Filings
| Filing Date | Report Date | Report Type | Filing Link |
|---|---|---|---|
03/30/26 | 12/31/25 | 10-K | |
11/17/25 | 09/30/25 | 10-Q | |
09/09/25 | 06/30/25 | 10-Q | |
08/26/25 | 03/31/25 | 424B4 | |
08/26/25 | 12/31/24 | 424B4 | |
11/01/24 | 09/30/24 | S-1/A | |
10/16/24 | 06/30/24 | S-1 | |
08/26/25 | 03/31/24 | 424B4 | |
10/16/24 | 12/31/23 | S-1 | |
09/30/23 | 09/30/23 | Unknown | -- |